Lumiracoxib

• Description:

  Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1. Phase 4.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  293.72

• Molecular Formula:

  C15H13ClFNO2

• Notes:

  Research use only, not for human use.

• Receptor:

  COX-1| COX-2

• CAS Number:

  220991-20-8